BGPT: MMP9 expression in BMDMs vs PMs

Explore by Goal

Quick Explanation Copied

I can’t truthfully plot **MMP9 expression in BMDMs vs PMs** from the provided research data, because none of the included raw excerpts report **BMDM (bone-marrow derived macrophage)** or **PM (peritoneal macrophage)** expression distributions. What I *can* visualize from the provided sources is **MMP9+ fractions** in **MCF-7 vs MDA-MB-231** cancer cells.

Long Explanation

Request: “MMP9 expression in BMDMs vs PMs”

Scientific check (data availability): none of the provided paper excerpts contain the required cell types/assay targets “BMDMs” and “PMs” with MMP9 expression distributions (e.g., FACS %MMP9+, MFI, bulk RNA). Therefore, I do not have grounds to create the specific BMDM vs PMs graph you asked for without introducing unsupported assumptions.

What I can visualize from your provided dataset: the October 29, 2025 paper reports MMP9 expression by FACS as %MMP9+ for MCF-7 and MDA-MB-231 (breast cancer cell lines), which is not BMDMs vs PMs.

Available raw visualizable signal (from provided excerpts)

Evidence basis (why this plot exists)

The paper excerpt states: MCF-7: 42% MMP9+ and MDA-MB-231: ~99% MMP9+ by FACS, with substantial single-cell heterogeneity.

Why your exact target (BMDMs vs PMs) isn’t shown

Missing in provided research data: No excerpt reports MMP9 expression distributions for macrophage subsets labeled “BMDMs” and “PMs”, nor does it provide the kind of cell-type-resolved measurements (e.g., FACS %MMP9+, mean MMP9 MFI, RNA-seq/targets normalized per macrophage type) needed for an apples-to-apples plot.

Scientific consequence: plotting anything “BMDM vs PM” from unrelated cell lines would be fabrication-by-proxy. I’m not going to do that.

Next action: locate the correct raw macrophage data in BGPT

Feedback:

Updated: June 10, 2026

Top Data Sources Export MCP

1. This study combines experimental evidence that MMP9 expression gates cell biophysics (size and deformability) with a computational Cellular Potts Model to show that biophysical differences between proteolytic and non-proteolytic cancer cells, governed by cell–cell adhesion, orchestrate the invasion of heterogeneous cell clusters and that mixed spheroids containing high-MMP9 cells at the invasive front exhibit maximal invasiveness through ECM remodeling and squeezing of softer cells. [2025]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. This study reveals a MMP9/RAGE-mediated feedforward loop whereby oxidative stress drives NF-κB–dependent neuroinflammation that impairs maturation of parvalbumin interneurons and their perineuronal nets, producing a persistent inhibitory/excitatory imbalance in schizophrenia; inhibiting MMP9 during development prevents long-term PVI/PNN deficits in mice, while in early psychosis patients elevated plasma sRAGE correlates with lower prefrontal GABA, especially in individuals with high-risk GCL GAG... [2019]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. MKL1 promotes lung cancer cell migration and invasion by epigenetically activating MMP9 transcription through recruitment of the ASH2-containing COMPASS-like histone H3K4 methyltransferase complex, a mechanism triggered by hypoxia and TGF-β that drives metastasis in vitro and in vivo. [2015]

9QualityResults Limitations Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. This study demonstrates that secreted MMP9 promotes angiogenesis more effectively than membrane-bound MMP9, highlighting the importance of MMP9 localization in tumor growth and vascularization. [2004]

8QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

5. The study shows that TET2 regulates MMP9 promoter demethylation and expression via 5hmC in human placental trophoblasts; downregulation of TET2 in preeclampsia reduces MMP9 levels, impairing trophoblast migration/invasion, with vitamin C able to partially rescue these effects, highlighting a TET2–MMP9 epigenetic pathway in PE pathogenesis. [2018]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Your requested comparison (BMDMs vs PMs) cannot be reconstructed from the provided excerpt set; the only directly mappable MMP9 “expression distribution” signal here is in cancer cell lines (MCF-7 vs MDA-MB-231), so any BMDM/PM plot would require new raw macrophage data.

Keep Exploring

What exact assay defines “MMP9 expression” in BMDMs vs PMs in the relevant studies (protein by flow vs RNA by qPCR/RNA-seq)?

Do BMDM vs PM differences persist under identical ex vivo stimulation and normalization, or are they stimulus-conditional?

Which macrophage markers and gating strategies are used to define BMDMs and PMs, and how do those definitions affect MMP9 distributions?

Analysis Wizard

It loads macrophage MMP9 raw measurements (FACS %MMP9+ or MFI, or expression counts) from the retrieved papers, normalizes to a common metric, then generates a side-by-side BMDM vs PM plot with confidence intervals.

Hypothesis Graveyard

A “BMDM vs PM difference” inferred from unrelated epithelial/cancer cell line MMP9 distributions is unlikely to hold because macrophage lineage and microenvironment strongly shape metalloproteinase regulation; it’s not supported by the provided evidence.

Assuming MMP9 levels are interchangeable across macrophage sources without type-specific raw data would be falsifiable by showing identical MMP9 expression distributions across BMDM and PM under matched assays—impossible to verify from current excerpts.

Potential Experiments

Isolate BMDMs and peritoneal macrophages from the same mouse strain, gate on live CD45+ leukocytes then macrophage markers, and measure MMP9 by flow cytometry (surface/staining or intracellular as appropriate) to quantify %MMP9+ and MFI; plot per-animal distributions with bootstrap CIs.

Perform matched RNA profiling from BMDM and PM subsets (same stimulation conditions and time) and quantify MMP9 transcript using consistent normalization; test whether MMP9 variance (not just mean) differs between sources using dispersion metrics.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize strict data provenance over pattern-matching; this can make answers shorter when the provided evidence doesn’t directly contain the requested cell types.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Traceable Claims in Immunology

Check what immune studies actually reported — results, scope, and sources you can verify.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources Export MCP

3. MKL1 promotes lung cancer cell migration and invasion by epigenetically activating MMP9 transcription through recruitment of the ASH2-containing COMPASS-like histone H3K4 methyltransferase complex, a mechanism triggered by hypoxia and TGF-β that drives metastasis in vitro and in vivo. [2015]

4. This study demonstrates that secreted MMP9 promotes angiogenesis more effectively than membrane-bound MMP9, highlighting the importance of MMP9 localization in tumor growth and vascularization. [2004]

12. Acrolein rapidly activates an EGFR-MAPK signaling cascade to induce MUC5AC mucin expression in human airway epithelial cells, via ligand shedding by ADAM17 and MMP9, with a potential longer-term boost from increased MMP9 and decreased TIMP3. [2005]

Ask a Follow-Up

Key Insight

Your requested comparison (BMDMs vs PMs) cannot be reconstructed from the provided excerpt set; the only directly mappable MMP9 “expression distribution” signal here is in cancer cell lines (MCF-7 vs MDA-MB-231), so any BMDM/PM plot would require new raw macrophage data.

Keep Exploring

What exact assay defines “MMP9 expression” in BMDMs vs PMs in the relevant studies (protein by flow vs RNA by qPCR/RNA-seq)?

Do BMDM vs PM differences persist under identical ex vivo stimulation and normalization, or are they stimulus-conditional?

Which macrophage markers and gating strategies are used to define BMDMs and PMs, and how do those definitions affect MMP9 distributions?

Analysis Wizard

It loads macrophage MMP9 raw measurements (FACS %MMP9+ or MFI, or expression counts) from the retrieved papers, normalizes to a common metric, then generates a side-by-side BMDM vs PM plot with confidence intervals.

Hypothesis Graveyard

A “BMDM vs PM difference” inferred from unrelated epithelial/cancer cell line MMP9 distributions is unlikely to hold because macrophage lineage and microenvironment strongly shape metalloproteinase regulation; it’s not supported by the provided evidence.

Assuming MMP9 levels are interchangeable across macrophage sources without type-specific raw data would be falsifiable by showing identical MMP9 expression distributions across BMDM and PM under matched assays—impossible to verify from current excerpts.

Potential Experiments

Isolate BMDMs and peritoneal macrophages from the same mouse strain, gate on live CD45+ leukocytes then macrophage markers, and measure MMP9 by flow cytometry (surface/staining or intracellular as appropriate) to quantify %MMP9+ and MFI; plot per-animal distributions with bootstrap CIs.

Perform matched RNA profiling from BMDM and PM subsets (same stimulation conditions and time) and quantify MMP9 transcript using consistent normalization; test whether MMP9 variance (not just mean) differs between sources using dispersion metrics.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize strict data provenance over pattern-matching; this can make answers shorter when the provided evidence doesn’t directly contain the requested cell types.

Stay current without chasing every paper.

My BGPT

Trending

Traceable Claims in Immunology

Check what immune studies actually reported — results, scope, and sources you can verify.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources ExportMCP

3. MKL1 promotes lung cancer cell migration and invasion by epigenetically activating MMP9 transcription through recruitment of the ASH2-containing COMPASS-like histone H3K4 methyltransferase complex, a mechanism triggered by hypoxia and TGF-β that drives metastasis in vitro and in vivo. [2015]

4. This study demonstrates that secreted MMP9 promotes angiogenesis more effectively than membrane-bound MMP9, highlighting the importance of MMP9 localization in tumor growth and vascularization. [2004]

12. Acrolein rapidly activates an EGFR-MAPK signaling cascade to induce MUC5AC mucin expression in human airway epithelial cells, via ligand shedding by ADAM17 and MMP9, with a potential longer-term boost from increased MMP9 and decreased TIMP3. [2005]

Ask a Follow-Up

Key Insight

Your requested comparison (BMDMs vs PMs) cannot be reconstructed from the provided excerpt set; the only directly mappable MMP9 “expression distribution” signal here is in cancer cell lines (MCF-7 vs MDA-MB-231), so any BMDM/PM plot would require new raw macrophage data.

Keep Exploring

What exact assay defines “MMP9 expression” in BMDMs vs PMs in the relevant studies (protein by flow vs RNA by qPCR/RNA-seq)?

Do BMDM vs PM differences persist under identical ex vivo stimulation and normalization, or are they stimulus-conditional?

Which macrophage markers and gating strategies are used to define BMDMs and PMs, and how do those definitions affect MMP9 distributions?

Analysis Wizard

It loads macrophage MMP9 raw measurements (FACS %MMP9+ or MFI, or expression counts) from the retrieved papers, normalizes to a common metric, then generates a side-by-side BMDM vs PM plot with confidence intervals.

Hypothesis Graveyard

A “BMDM vs PM difference” inferred from unrelated epithelial/cancer cell line MMP9 distributions is unlikely to hold because macrophage lineage and microenvironment strongly shape metalloproteinase regulation; it’s not supported by the provided evidence.

Assuming MMP9 levels are interchangeable across macrophage sources without type-specific raw data would be falsifiable by showing identical MMP9 expression distributions across BMDM and PM under matched assays—impossible to verify from current excerpts.

Potential Experiments

Isolate BMDMs and peritoneal macrophages from the same mouse strain, gate on live CD45+ leukocytes then macrophage markers, and measure MMP9 by flow cytometry (surface/staining or intracellular as appropriate) to quantify %MMP9+ and MFI; plot per-animal distributions with bootstrap CIs.

Perform matched RNA profiling from BMDM and PM subsets (same stimulation conditions and time) and quantify MMP9 transcript using consistent normalization; test whether MMP9 variance (not just mean) differs between sources using dispersion metrics.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize strict data provenance over pattern-matching; this can make answers shorter when the provided evidence doesn’t directly contain the requested cell types.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP